ARL2 and neoplasm: Figure 7B illustrates the proteins concerned with the most significant differences (p values < 0.01) and Table S3 describes all other cases (for 0.01 < p < 0.05). For 17 other proteins (AP2S1, ARL2, DJB11, ECHA, FABP5, FINC, H2AJ, HMCS2, HNRPK, IDH3A, LYPA1, NCPR, PA2G4, PICAL, PPAC, SRSF2, VIME), change in abundance did not followed tumor progression (Table S3).